Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
Rhea-AI Summary
Assertio Holdings (NASDAQ:ASRT) has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss Q2 results and provide updates on 2025 strategic plans.
Investors can access the webcast through Assertio's investor relations website, with a recommended connection time of 10 minutes before the start. For telephone participants, the dial-in number is +1-646-307-1963 with call ID 3278948. A replay will be available approximately two hours after the call on the company's investor website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ASRT gained 2.93%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans.
To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.
A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.
About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
mkreps@darrowir.com
FAQ
When will Assertio Holdings (ASRT) report Q2 2025 earnings?
How can investors access Assertio's Q2 2025 earnings call?
What time is Assertio Holdings' Q2 2025 earnings call?
Will there be a replay available of Assertio's Q2 2025 earnings call?
